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The present study aimed at assessing the other sites as 
the carcinoma spreads, as well as therapeutic results, in 
larynx preservation and patient survival. Study type: It is a 
Longitudinal Historical Cohort Study, a retrospective clinical 
study. Materials and methods: A hundred and sixty (160) 
patients treated at ‘Escola Paulista de Medicina’ (‘Paulista’ 
Medical School) - São Paulo Hospital, from January 1988 
to December 2004 were examined as for the spreading of 
their larynx carcinoma. Those patients whose evaluations 
were at least two years old after treatment were the only 
ones accepted. The parametric tests used were: Test X2, 
Fisher’s test, and Kaplan-Meier’s curve. Results: The posterior 
commissure and the infraglottis were significant in terms of 
the laryngectomy: glottal tumors AC: (p=0.03) AP: (p=0.0001); 
AC: (p=0.0007) AP: (p<0.0001), respectively. The infraglottis 
was significant in G+SG tumors in AP: (p=0.04) and in death 
rate AP: (p=0.03). Conclusion: total laryngectomy is the 
treatment of choice in the presence of total involvement of 
the posterior commissure and the infraglottis. The latter may 
compromise survival, according to local invasion, even in the 
presence of free surgical margins. 
Keywords: larynx, surgery, cancer, prognosis, survival, 
treatment.
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INTRODUCTION
It is important to understand the dissemination of 
endolaryngeal carcinoma for staging and treatment aiming 
at locoregional control and survival.1,2
The need to study the internal structures or subsites 
of the larynx (anterior commissure, posterior commissure, 
ventricle and infraglottis) since their origin, evolution, and 
their relation with the invasion and barrier paths to the 
tumor have been well documented in the literature.1-16 The 
objective of this study was to assess the laryngeal regions 
and subsites of 160 patients with laryngeal carcinoma, in 
the period between January 1998 and December 2004. Mo-
reover, it aimed to check the proportion of affected subsites 
and their influence on determining conservative or radical 
surgery (total laryngectomy), as well as the repercussion 
on local control, organ preservation and survival.
This research was analyzed and approved under 
No. CEP 1610/04 by the Research Ethics Committee of the 
Universidade Federal de São Paulo.
MATERIALS AND METHODS
First, a total of 200 medical charts of patients with 
laryngeal carcinoma were reviewed. Patients were seen 
at the Escola Paulista de Medicina - Hospital São Paulo, 
in the period from January 1998 to December 2004. The 
tumors were classified according to the TNM and AJCC/
UICC systems (2002).
Next, a database was created for patients with initial 
indication for surgical treatment.
The main objective was to assess the involvement 
level of the internal structures or subsites (anterior commis-
sure, posterior commissure, ventricle and infraglottis) by 
the neoplasm. Furthermore, to evaluate the repercussion 
of these structures affected by the tumor have in treatment, 
local control, organ preservation, and survival.
These structures were studied through specific clini-
cal examinations, including videotelelaryngoscopy, image 
exams such as computerized tomography of the larynx, 
and endoscopic examination (nasal fibrobronchoscopy). 
All exams required for diagnosis, staging and preoperative 
evaluation were also performed. Biopsy was performed 
through microsurgery of the larynx.
Inclusion Criteria for the Database: Patients with 
full description of structure involvement, through clinical 
assessment, pathologic evaluation, diagnosis, staging, tre-
atment, condition of surgical margins, and progression in 
the referenced time, patient’s condition with information 
updated and recorded until December 2004.
Exclusion Criteria for the Database: Patients with 
incomplete data, no updated record, follow-up for less 
than two years after diagnosis and treatment, or loss of 
control. Patients with inaccurate description of internal 
structure involvement, or with incomplete evaluations, 
either by clinical, endoscopy, or image exams. Patients 
who underwent surgery in 2004 were also excluded since 
they had not been followed-up for at least two years during 
the referenced period.
According to these criteria, 160 patients were se-
lected for the database. However, 17 patients from this 
group, initially with surgical indication, went to radio-
therapy and/or chemotherapy due to clinical conditions 
or refusal to surgery. Only two patients were submitted 
to microsurgery of the larynx to diagnose and assess the 
endolarynx, without tracheostomy: one T1 patient and one 
T2 patient. The other 15 patients were six T4 patients and 
nine T3 patients, who underwent tracheostomy, in addition 
to microsurgery of the larynx. They were included in the 
initial database for having full description of the subsites 
affected by the tumor, besides other items. In this case, 
the pathologic evaluation and the clinic evaluation were 
considered the same, since there was no change in the 
results.
The remaining 143 patients in the database went to 
surgical treatment: partial or total laryngectomy according 
to previous indication, staging, as well as preoperative and 
intraoperative presentation of the neoplasm.
Patients with the disease after clinical or surgical 
treatment had the same value as patients who died due to 
the disease, in the period in which survival was studied.
The mean age was 58.9 years. The predominant 
sex was male, 87.5%. Dysphonia was the main symptom, 
with 79.4%, lasting 11.9 months in average. A total of 
89.4% of patients were smokers and 50% suffered from 
alcoholism.
The research was developed by a longitudinal 
historical cohort study (retrospective clinical study). The 
nonparametric tests used were X2 test, Fisher test and the 
Kaplan-Meier curve, and the significance level was 5%.
RESULTS
Most laryngeal carcinomas presented originated 
from or  were located in the glottis (CA: n=105 and PA: 
n=100), according to the following results:
 
List of patients (n) with origin or location of the 
tumor in the larynx. 
This list is shown in Figures 1 and 2.
Charts 1 and 2 display tumor staging and the relation 
of origin in the larynx (glottic or supraglottic) in clinical 
and pathological assessment, respectively.
Proportion of involved subsites in relation to tumor 
site and type of surgery - conservative vs. total
Tables 1 and 2 show the involvement degree of the 
anterior commissure due to the neoplasm, by clinical and 
pathological assessment between conservative laryngec-
tomy and total laryngectomy.
Tables 3 and 4 show the involvement degree of the 
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posterior commissure due to  the neoplasm, by clinical 
and pathological assessment between conservative laryn-
gectomy and total laryngectomy.
Tables 7 and 8 show the involvement degree of the 
infraglottis due to the neoplasm, by clinical and patholo-
gical assessment between conservative laryngectomy and 
total laryngectomy.
Tables 1 to 8.
G: Glottic tumors G+SG: Glottic tumors extending 
to the supraglottis
SG: Supraglottic tumors SG+G: Supraglottic tumors 
Figures 1 and 2. 
CA: Clinical assessment: number of patients with laryngeal regions 
involved by the tumor
PA: Pathological assessment: number of patients with laryngeal regions 
involved by the tumor
G: Glottic Tumors  (CA: 69 patients, PA: 65 patients)
G + SG: Glottic tumors extending to the supraglottis  (CA: 36 patients, 
PA: 35 patients)
SG: Supraglottic tumors (CA: 17 patients, PA: 15 patients)
SG + G: Supraglottic tumors extending to the glottis (CA: 32 patients, 
PA: 31 patients)
T: Transglottic tumors (CA: 6 patients, PA: 14 patients)
Note: In tumors (T): in CA: 5 patients with glottic origin and 1 patient 
with supraglottic origin. In PA: 10 patients with glottic origin and 4 
patients with supraglottic origin.
Chart 1. Glottic origin tumor (T) staging in clinical and pathological 
assessment.
TUMOR 
(T)
CLINICAL ASSESSMENT
PATHOLOGICAL 
ASSESSMENT
G G+SG T G G+ SG T
n % n % n % n % n % n % 
T1a 12 17.3 0 0.0 0 0.0 12 18.4 0 0.0 0 0.0
T1b 19 27.5 1 2.7 0 0.0 20 30.7 0 0.0 0 0.0
T2 17 24.6 8 22.2 0 0.0 13 20.0 6 17.1 0 0.0
T3 13 18.8 18 50.0 0 0.0 11 16.9 15 42.8 0 0.0
T4 8 11.5 9 25.0 5 100.0 9 13.8 14 40.0
10 
100.0
TOTAL
69 
100.0
36 
100.0
5 100.0
65 
100.0
35 
100.0
10 
100.0
Chart 2. Supraglottic origin tumor (T) staging in clinical and patholo-
gical assessment.
TUMOR 
(T)
CLINICAL ASSESSMENT
PATHOLOGICAL 
ASSESSMENT
SG SG+G T SG SG+G T
n % n % n % n % n % n % 
T1 3 17.6 0 0.0 0 0.0 2 13.3 1 3.22 0 0.0
T2 7 41.1 3 9.37 0 0.0 6 40.0 5 16.1 0 0.0
T3 4 23.5 18 56.2 0 0.0 3 20.0 16 51.6 0 0.0
T4 3 17.6 11 34.3 1 100.0 4 26.6 9 29.0 4 100.0
TOTAL
17 
100.0
32 
100.0
1 
100.0
15 
100.0
31 
100.0
4 
100.0
extending to the glottis
AC: Anterior commissure PC: Posterior commissure 
or interarytenoid space 
V: Ventricle IG: Infraglottis
W/O: Absence of subsite involvement 
With: Presence of subsite involvement
N: Absolute number of cases           %: Percentage 
corresponding to (N) of cases
C.L.: Conservative laryngectomy 
T. L: Total laryngectomy
Chart 4 shows the number of conservative surgeries 
in relation to tumor (T) extension in the larynx.
*Four patients with involved margins: 3 patients: 
submitted to: Frontolateral Laryngectomy: T1a, T1b, T2. 1 
patient: submitted to: LHSC-CHP: T3. All were referred to 
RT, only one patient died (disease).
*Partial surgery converted to total: 4 patients due to 
local recurrence and one by chronic aspiration (HSGL).
Tables 9 and 10 show the number of deaths in re-
lation to the subsite that interfered with survival according 
to its degree of involvement in clinical and pathological 
assessment.
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Chart 3. Statistical distribution of the type of treatment in relation to the tumor (T).
Type of Surgery
Tumor
(T)
No 
surgery
n %
C
n %
PFLL 
n %
HL
n %
HSGL 
n %
PSCL
CHEP II
n %
PSCL
CHEP I
n %
PSCL
CHP
n %
 TL
n %
TOTAL
n %
T1a 1 0,62 8 4,96 3 1,86 0 0,0 2 1,24 1 0,62 0 0,0 0 0,0 0 0,0 15 9,3
T1b 0 0,0 4 2,51 12 7,54 2 1,25 1 0,62 1 0,62 1 0,62 0 0,0 0 0,0 21 13,2
T2 1 0,62 1 0,62  9 5,60 2 1,24 3 1,86 8 4,98 5 3,11 2 1,24 4 2,49 35 21,8
T3 9 5,62 0 0,0  0 0,0 0 0,0 0 0,0 1 0,62 2 1,25 3 1,87 37 23,1 52 32,5
T4 6 3,76 0 0,0 0 0,0 0 0,0 0 0,0 0 0,0 0 0,0 0 0,0 31 19,43 37 23,2
Total 17 10,6 13 8,12 24 15 4 2,5 6 3,75 11 6,87 8 5 5 3,12 72 45 160 100
Key:
C: Chordectomy
PFLL: Partial frontolateral laryngectomy
HL: Hemilaryngectomy
HSGL: Horizontal supraglottic laryngectomy
PSCL: Partial supracricoid laryngectomy
CHEP II: Reconstruction after type II cricohyoidoepiglottopexy 
CHEP I: Reconstruction after type I cricohyoidoepiglottopexy
CHP: Reconstruction after type II cricohyoidopexy 
TL: Total laryngectomy 
No surgery: 17 patients only underwent larynx microsurgery and tracheostomy, except two patients (T1 and T2, respectively) who had only larynx 
microsurgery. All patients were referred  to radiation therapy and/or chemotherapy. One patient (T1) and five patients (T3) survived with no disease, 
the remaining (n=11) had a negative course of the disease.
Table 1. Statistical distribution of the anterior commissure in the site of neoplasm vs. type of laryngectomy - clinical assessment.
ANTERIOR COMMISSURE (AC)
 G G+SG SG SG+G
 No Involvement No Involvement No Involvement No Involvement
Type N % N % N % N % N % N % N % N %
C.L. 19  70,4 33 75,0 3 23,1 9 40,9 12 80,0 0 0,0 5 31,3 10 33,3
T.L. 8  29,6 11 25,0 10 76,9 13 59,1 3 20,0 0 0,0 11 68,8 20 66,7
TOTAL 27 100,0 44 100,0 13 100,0 22 100,0 15 100,0 0 0,0 16 100,0
30 
100,0
Table 2. Statistical distribution of the anterior commissure in the site of neoplasm neoplasm vs. type of laryngectomy - clinical assessment. 
ANTERIOR COMMISSURE (AC)
 G G+SG SG SG+G
 No Involvement No Involvement No Involvement No Involvement
Type N % N % N % N % N % N % N % N %
C.L. 25 86,2 24 64,9 5 38,5 11 47,8 5 71,4 6 100,0 18 94,7
13 
100,0
T.L. 4 13,8 13 35,1 8 61,5 12 52,2 2 28,6 0 0,0 1 5,3 0  0,0
TOTAL 29 100,0 37 100,0 13 100,0 23 100,0 7 100,0 6 0,0 19 100,0 13 100,0
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Table 3. Statistical distribution of the posterior commissure in the site of neoplasm vs. type of laryngectomy - clinical assessment.
POSTERIOR COMMISSURE (PC)
 G G+SG SG SG+G
 W/O With W/O With W/O With W/O With
Type N % N % N % N % N % N % N % N %
C.L. 46 79,3 6 46,2 10 43,5 2 16,7 11 84,6 1 50,0 5 23,8 4 36,4
T.L. 12 20,7 7 53,8 13 56,5 10 83,3 2 15,4 1 50,0 16 76,2 7 63,6
TOTAL 58 100,0 13 100,0 23 100,0 12 100,0 13 100,0 2 100,0 21 100,0 11 100,0
Table 4. Statistical distribution of the posterior commissure in the site of neoplasm vs. type of laryngectomy - pathological assessment.
POSTERIOR COMMISSURE (PC)
 G G+SG SG SG+G
 W/O With W/O With W/O With W/O With
Type N % N % N % N % N % N % N % N %
C.L. 48 82,8 1 12,5 13 54,2 3 25,0 9 81,8 2 100,0 9 36,0 1 16,7
T.L. 10 17,2 7 87,5 11 45,8 9 75,0 2 18,2 0 0 16 64,0 5 83,3
TOTAL 58 100,0 8 100,0 24 100,0 12 100,0 25 100,0 6 100,0 25 100,0 6 100,0
Table 5. Statistical distribution of the ventricle in the site of neoplasm vs. type of laryngectomy - clinical assessment. 
VENTRICLE (V)
 G G+SG SG SG+G
 W/O With W/O With W/O With W/O With
Type N % N % N % N % N % N % N % N %
C.L. 48 76,2 4 50,0 9 34,6 3 33,3 12 80,0 0 0,0 8 34,8 1 11,1
T.L. 15 23,8 4 50,0 17 65,4 6 66,7 3 20,0 0 0,0 15 65,2 8 88,9
TOTAL 63 100,0 8 100,0 26 100,0 9 100,0 15 100,0 0 0,0 23 100,0 9 100,0
Table 6. Statistical distribution of the ventricle in the site of neoplasm vs. type of laryngectomy
VENTRICLE (V)
 G G+SG SG SG+G
 W/O With W/O With W/O With W/O With
Type N % N % N % N % N % N % N % N %
C.L. 43 79,6 6 50,0 13 46,4 3 37,5 11 84,6 0 0,0 9 39,1 1 12,5
T.L. 11 20,4 6 50,0 15 53,6 5 62,5 2 15,4 0 0,0 14 60,9 7 87,5
TOTAL 54 100,0 12 100,0 28 100,0 8 100,0 13 100,0 0 0,0 23 100,0 8 100,0
Table 7. Statistical distribution of the infraglottis in the site of neoplasm vs. type of laryngectomy - clinical assessment.
INFRAGLOTTIS (IG)
 G G+SG SG SG+G
 W/O With W/O With W/O With W/O With
Type N % N % N % N % N % N % N % N %
C.L. 49 81,7 3 27,3 11 40,7 1 12,5 12 80,0 0 0,0 9 28,1 0 0,0
T.L. 11 18,3 8 72,7 16 59,3 7 87,5 3 20,0 0 0,0 23 71,9 0 0,0
TOTAL 60 100,0 11 100,0 27 100,0 8 100,0 15 100,0 0 0,0 32 100,0 0 0,0
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Tabela 8. Distribuição estatística da infraglote na localização neoplásica x tipo de laringectomia - avaliação patológica.
INFRAGLOTTIS (IG)
 G G+SG SG SG+G
 W/O With W/O With W/O With W/O With
Type N % N % N % N % N % N % N % N %
C.L. 47 87,0 2 16,7 11 52,4 2 13,3 11 84,6 0 0,0 10 32,3 0 0,0
T.L. 7 13,0 10 83,3 10 47,6 13 86,7 2 15,4 0 0,0 21 67,7 0 0,0
TOTAL 54 
100,0
12 100,0 21 100,0 15 10,0 13 100,0 0 0,0 31 100,0 0 0,0
Chart 4. Frequency distribution of conservative surgery in relation to the tumor (T).
Tipos de Cirurgias Conservadoras
Tumor (T)
Chordec-
tomy
Frontolateral Laryn-
gectomy
Hemi-
laryngectomy
PSCL
CHEP II
PSCL
CHEP I
PSCL
CHP
HSGL TOTAL
T1a 8* *3 0 1 0 0 2 14
T1b 4* *12* 2 1 1 0 1 21
T2 1 *9 2  8* 5 2  3* 30
T3 0 0 0 1 2 *3 0 6
Total 13 24 4 11 8 5 6 71
*Four patients with involved margins: 3 patients: submitted to: Frontolateral Laryngectomy: T1a, T1b, T2. 1 patient: submitted to: LHSC-CHP: T3. 
All were referred to RT, only one patient died (disease).
*Partial surgery converted to total: 4 patients due to local recurrence and one by chronic aspiration (HSGL).
Significance degree of involved subsites for total laryngectomy
Figure 3 is a graphic representation of the larynx subsites.
Anterior commissure Posterior commissure Ventricle Infraglottis
A) Tumors G A) Tumors G A) Tumors G A) Tumors G
 AC: (p) = 0.87  AC: (p) = 0.03  AC: (p) = 0.24  AC: (p) = 0.0007
 PA: (p) = 0.09  PA: (p) = 0.0001  PA: (p) = 0.07  PA: (p) < 0.0001
    
B) Tumors G + SG B) Tumors G + SG B) Tumors G + SG B) Tumors G + SG
 AC: (p) = 0.48  AC: (p) = 0.22  AC: (p) = 1.000  AC: (p) = 0.29
 PA: (p) = 0.84  PA: (p) = 0.19  PA: (p) = 0.96  PA: (p) = 0.04
    
C) Tumors SG C) Tumors SG C) Tumors SG C) Tumors SG
 AC: Test not applicable  AC: (p) = 0.37  AC: Test not applicable  AC: Test not applicable
 PA: (p) = 0.46  PA: (p) = 1.000  PA: Test not applicable  AC: Test not applicable
    
D) Tumors SG+G D) Tumors SG+G D) Tumors SG+G D) Tumors SG+G
 AC: (p) = 1.00  AC: (p) = 0.73  AC: (p) = 0.36  AC: Test not applicable
 PA: (p) = 1.00  PA: (p) = 0.67  PA: (p) = 0.34  AC: Test not applicable
Key:
G: Glottic tumors  G+SG: Glottic tumors extending to the supraglottis
SG: Supraglottic tumors SG+G: Supraglottic tumors extending to the glottis
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Table 9. Statistical distribution of cases of death in the presence or absence of infraglottis involvement - clinical assessment.
  Survival
Total
  Alive Dead
  N % N % N %
Infraglottis 0 125 85,6% 11 78,6% 136 85,0%
Clinical aspect 1 21 14,4% 3 21,4% 24 15,0%
Total  146 100,0% 14 100,0% 160 100,0%
Chi-square test: (p) = 0.754
Table 10. Statistical distribution of cases of death in the presence or absence of infraglottic involvement - pathological assessment.
  Survival
Total
  Alive Dead
  N % N % N %
Infraglottis 0 116 79,5% 7 50,0% 123 76,9%
Pathological aspect 1 30 20,5% 7 50,0% 37 23,1%
Total  146 100,0% 14 100,0% 160 100,0%
Chi-square test: (p) = 0.030 *
Figure 3. Survival curve from onset of symptoms to last visit - Has 
no legend.
KAPLAN MEIER SURVIVAL CURVE
The survival curve from onset of symptoms up to 
last visit is shown in Figure 4. 
DISCUSSION
In our study, the most frequent initial neoplasm 
site was the glottis (CA: 105; PA: 100). In transglottic tu-
mors, the initial neoplasm site was also in the glottis of 
five patients in clinical assessment and of 10 patients in 
pathological assessment.
The main goal of the surgical treatment is to eradi-
cate the primary tumor with free surgical margins, preserve 
the organ when necessary, in addition to cure or longer 
survival.
A total of 71 partial and 72 total laryngectomies 
were performed.
The subsites analyzed showed unique characteristics 
in terms of tumor invasion according to their anatomic 
formation.1,2,8,12
We started studying the subsites by the anterior 
commissure and its importance in indicating the surgical 
technique. The anterior commissure has important cha-
racteristics that should be taken into account in neoplasm 
dissemination, when approaching it surgically.1-12
Its embryologic and anatomic formation has dra-
wn attention of many authors, when studying laryngeal 
cancer dissemination.8 These formation aspects should 
be pointed out to indicate the open technique in initial 
tumors (T1 and T2). The main objective is tumor resection 
with free margins, and, consequently, local control of the 
disease.2,4,6-12 According to studies conducted by Rucci et 
al., the anterior commissure and the Broyles tendon have 
a clearly defined plane in which the blood vessel distri-
bution is local, superficial, and restricted to the mucosa, 
with late maturation of these phonatory structures.8,9,12 
This characteristic would provide slower dissemination 
of the neoplasm.8 The anterior commissure is considered 
a barrier by many authors.2,6,7 However, there is a weak 
point which is the insertion of the Broyles tendon, where 
there is no internal perichondrium, facilitating the inferior 
dissemination of supraglottic tumors and invasion of the 
cartilage.2,7,8 The approach of the anterior commissure in 
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initial tumors has generated controversies in the literature 
regarding treatment.5,9,17 The authors supporting surgery 
suggest  better local control and lower relapse for T1 and 
T2 tumors, with different results among the various surgi-
cal techniques.4,8,10,11 On the other hand, the supporters of 
radiation therapy emphasize local control similar to that 
obtained by surgery and better vocal quality.5
At the Escola Paulista de Medicina, after confirming 
anterior commissure involvement by the tumor, open sur-
gery was indicated in most cases, except for five cases, in 
which endoscopic chordectomy was performed (four T1b 
patients and one T2 patient).
Sixty-seven patients underwent partial surgery with 
free margins. Two of them died due to local recurrence, the 
others are alive and disease-free. Four patients underwent 
conservative surgery and had involved margins. All four 
were referred to radiation therapy and one patient died 
because of the disease.
During the period studied, there was a clear ten-
dency to approach the anterior commissure through open 
technique, especially through frontolateral laryngectomy 
for T1b (n=12) and T2 (n=9) tumors, and supracricoid 
laryngectomy for T2 (n=15) tumors, chiefly for those 
with decreased vocal fold mobility, and some T3 (n=6) 
tumors.
The results of 71 patients who underwent partial 
surgery were satisfactory, since only five patients had their 
surgeries converted to total laryngectomy; in that, four due 
to local relapse and one due to chronic aspiration. Two 
out of these five patients remained disease-free.
The study of the anterior commissure through 
partial surgeries was impaired due to insufficient number 
of procedures. However, the approach to the anterior 
commissure when treating initial tumors (T1b, T2) and 
rare T3 to preserve the larynx showed better results with 
the open technique.
The main objective of surgical and open approach is 
primary tumor resolution. The aim is to obtain free margins, 
local control with larynx preservation, regardless of higher 
or lower level of anterior commissure ionvolvement.8
In our study, greater involvement of anterior com-
missure in partial surgery procedures was found in tumors 
originating from or located in the glottis (G): CA: n=33 
(75%), PA: n=24 (64.9%) and extending to the supraglottis 
(G+SG): CA: n=9 (40.9%), PA: n=11 (47.8%) and in supra-
glottic tumors extending to the glottis (SG+G): CA: n=10 
(33.3%), PA: n=13 (100%).
On the other hand, in only supraglottic tumors (SG): 
CA: n=0 (0.0%), PA: n=6 (100.0%), the anterior commissure 
was less marked. 
In regards to the sum of partial and total surgeries, 
the anterior commissure involvement was not significant 
for total laryngectomy in all tumors originated from or 
located in the glottis or supraglottis, as shown in the follo-
wing results: (G): CA (p=0.87), PA (p=0.09); (G+SG): CA 
(p=0.48), PA (p=0.84); (SG): CA: non applicable; PA: (p= 
0.46) and (SG+G): CA (p= 1.000), PA: (p=1.000).
The presence of anterior commissure involvement 
in primary of secondary form in our patients with initial 
tumors showed better progression when open surgery was 
performed, in agreement with other authors.4,8-11
The posterior commissure was significant for to-
tal laryngectomy in glottic tumors CA: (p=0.03) and PA: 
(p=0.0001). It is difficult to define the posterior commissure 
in terms of  terminology, location, and components. Many 
authors disagree about the term posterior commissure, 
preferring to call it interarytenoid space or posterior glottic 
space. Rucci described it as a cartilaginous plane including 
the arytenoid medial surface, the vocal process, glands 
and blood vessels on the lamina propria, elastic lamina, 
and internal cricoarytenoid ligaments on both sides.8,12,13 
Its structures are related to the sphincter function and it 
has an early maturation process. Consequently, it would 
make the neoplasm dissemination through the posterior 
commissure occur in a faster and more intense manner.8 
Most tumors affecting the posterior commissure are located 
on the posterior two thirds of the vocal folds.13,14 The mu-
cosa, in this site, is intimately attached to the arytenoids, 
and when the tumor reaches the thyroarytenoid muscle, 
it spreads through the paraglottic space, arytenoids, cri-
coarytenoid joint, and postcricoid region.13 Through the 
cricoarytenoid ligaments it quickly reaches the infraglottis.13 
The tumor advance towards the cricoarytenoid joint 
and the infraglottis may render the conservative surgery 
unfeasible.13,14 This type of neoplasm evolution explain 
the greater involvement of the posterior commissure (G): 
CA: (p) = 0.03; PA: (p) = 0.0001 and of the infraglottis (G): 
CA: (p) = 0.0007; PA: (p) = 0.0001 and (G+SG): PA: (p) = 
0.04, which in our study made the conservative surgery 
unfeasible, especially in glottic tumors. The infraglottis is a 
subsite that can generate false-negative1 results, during its 
assessment in an attempt to surgically preserve the larynx, 
as well as its prognosis in regards to survival, according 
to results presented. 1,15 This is justified by the presence of 
neoplasm mucosal invasion in the fixed part of the infra-
glottis, where the superficial branches of the cricothyroid 
artery are found.15 These branches work as a means for 
diffusion, developing prelaryngeal, pretracheal, and/or 
paratracheal metastases, adjacent to the tracheostoma.15 
This condition was reproduced in our patients, according 
to the records presented by the death rates in the patho-
logical assessment (PA: (p) = 0.03).
The ventricle worked as an additional subsite in 
disseminating the tumor, showing an even more advan-
ced stage of the disease, with no repercussion for radical 
treatment.
The predominance of patients with high posterior 
commissure and infraglottis involvement was well do-
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cumented by the presence of T3 tumors (n=52) and T4 
tumors (n=37), in which total laryngectomy demonstrated 
to be the best treatment for local control and for survival. 
Radical treatment, associated or not to radiation therapy 
for advanced tumors has brought similar results in regards 
to survival in the literature.19,20
Today there is a trend to treat T3 tumors to preserve 
the larynx, through organ preservation protocols, in addi-
tion to surgery, such as supracricoid laryngectomy.18,19,21 
When surgical preservation is indicated, it is important 
to point out the difference between the fixation of vocal 
folds and of arytenoids.16,21 The first does not necessarily 
invalidate partial surgery, since the most frequent cause 
is invasion of the thyroarytenoid muscle, while the latter 
can mean involvement of the cricoarytenoid articulation, 
making it impossible to  preserve the larynx.13,16 Laccour-
reye clearly demonstrated the feasibility of the articulation, 
and, therefore, the possibility of preserving the larynx 
with neoadjuvant chemotherapy, prior to the supracricoid 
laryngectomy.20,21
Clinical preservation was well supported through 
randomized protocols from the Veterans Affairs Laryngeal 
Cancer Study Group.23
Today, the results improved with concomitant che-
mo and radiation therapy regimens.24
Other studies with induction chemotherapy for 
locally advanced tumors showed larynx preservation in 
44% of cases, with no increase in survival.25
Responses higher than 50% for T3 and T4 tumors 
through neoadjuvant chemotherapy can favor indications 
for supracricoid laryngectomy.22 However, for unsatisfac-
tory responses or important damage to the larynx (T4), 
the management is total laryngectomy.26-28
Unfortunately, in our study, patients (T3 and T4 
tumors) referred to clinical treatment did not progress well. 
Only five patients with tumors (T3) stayed alive with no 
carcinoma; the others died from the disease.
Lefebvre had already pointed out that the anatomic 
preservation of the larynx through organ preservation pro-
tocols would not always mean a functional larynx.3
The satisfactory results obtained by our patients 
through the Kaplan Meier curve are due to appropriate 
surgical treatment, both in conservative and total surgery, 
to achieve free margins. The indication of the surgical tech-
nique was according to staging and degree of involvement 
of subsites, to reach local control and better survival.
CONCLUSIONS
The involvement of the anterior commissure, espe-
cially in initial tumors (T1, T2) and rare T3 with possible 
surgical preservation of the larynx is better treated with 
open surgery. Hence, frontolateral laryngectomy and 
supracricoid laryngectomy showed to be effective in 
obtaining free surgical margins, local control and organ 
preservation in initial tumors and T3 tumors selected, re-
gardless if the level of anterior commissure involvement 
is primary or secondary.
The ventricle represents an additional site in disse-
minating the disease.
The greater involvement of the posterior commis-
sure and infraglottis require total laryngectomy for being 
the most suitable treatment to obtain better locoregional 
control. However, the degree of involvement of the infra-
glottis may compromise survival even when free margins 
are present, in total laryngectomies.
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